Fresenius Medical Care AG 2024 AR2

The report outlines Fresenius Medical Care's performance in 2024, marking the second year of its three-year turnaround and transformation journey. The company successfully executed its FME25 transformation program, achieving 567 million euros in recurring savings and raising its total savings target to 750 million euros. Key highlights include a 25% reduction in Scope 1 and 2 CO2e emissions compared to 2020, and receiving FDA approval for the 5008X Hemodialysis System to deliver high-volume hemodiafiltration in the U.S. Additionally, the company optimized its portfolio by divesting clinic operations in Latin America, Sub-Saharan Africa, and Türkiye, and returned to the DAX 40 index.

Company: Fresenius Medical Care AG

Sector: Health Care

Country: Germany

Year: 2024

Type: AR2

Pages: 374

Back to company

Fresenius Medical Care AG

Fresenius Medical Care AG 2024 Annual Report

Annual Report

The report outlines Fresenius Medical Care's performance in 2024, marking the second year of its three-year turnaround and transformation journey. The company successfully executed its FME25 transformation program, achieving 567 million euros in recurring savings and raising its total savings target to 750 million euros. Key highlights include a 25% reduction in Scope 1 and 2 CO2e emissions compared to 2020, and receiving FDA approval for the 5008X Hemodialysis System to deliver high-volume hemodiafiltration in the U.S. Additionally, the company optimized its portfolio by divesting clinic operations in Latin America, Sub-Saharan Africa, and Türkiye, and returned to the DAX 40 index.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Jan 1, 2024 - Dec 31, 2024

Fiscal Year

2024

Type

Annual Report with Sustainability Disclosures

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Assurance

Assurance Provider

Assurance Standard

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Scope 3:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Net Zero Target

Employees